Your browser version may not work well with NCBI's Web applications. More information here...
1: Science. 1998 Aug 21;281(5380):1191-3.Click here to read Links
Comment in:
Science. 1998 Aug 21;281(5380):1122-4.

Prevention of allogeneic fetal rejection by tryptophan catabolism.

Program in Molecular Immunology, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA 30912, USA.

In 1953 Medawar pointed out that survival of the genetically disparate (allogeneic) mammalian conceptus contradicts the laws of tissue transplantation. Rapid T cell-induced rejection of all allogeneic concepti occurred when pregnant mice were treated with a pharmacologic inhibitor of indoleamine 2,3-dioxygenase (IDO), a tryptophan-catabolizing enzyme expressed by trophoblasts and macrophages. Thus, by catabolizing tryptophan, the mammalian conceptus suppresses T cell activity and defends itself against rejection.

PMID: 9712583 [PubMed - indexed for MEDLINE]